Correction to "MicroRNA-320a suppresses tumor progression by targeting PBX3 in gastric cancer and is downregulated by DNA methylation".

[This corrects the article on p. 842 in vol. 11, PMID: 31662823.]. ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.

Core Tip: This is a correction to "MicroRNA-320a suppresses tumor progression by targeting PBX3 in gastric cancer and is downregulated by DNA methylation".

CORRECTION

Correction to: Li YS, Zou Y, Dai DQ. MicroRNA-320a suppresses tumor progression by targeting PBX3 in gastric cancer and is downregulated by DNA methylation. World J Gastrointest Oncol 2019; 11(10): 842-856 PMID: 31662823 DOI: 10.4251/wjgo.v11.i10.842.

We recently read our manuscript published in the World Journal of Gastrointestinal Oncology (Manuscript NO: 48527, DOI: 10.4251/wjgo.v11.i10.842), we have carefully rechecked the original data of Figure 3, Part.B, and found that 0 h group in the BGC-823 cell wound scratch assay was misapplied. Therefore, we are writing to apply for the modification of Figure 3, Part.B. The revised images are shown in this Correction (Figure 1). We feel deeply sorry for this mistake during the proofreading process. This correction does not alter any interpretation of the results or conclusion of this study[1].

Figure 1

Part.B. Overexpression of miR-320a suppressed gastric cancer cell migration and invasion.

We apologize for any inconvenience caused by this mistake.